«      »

Pfizer Halts Tanezumab Studies For Back Pain, Diabetes – Wall Street Journal

Pfizer Halts Tanezumab Studies For Back Pain , Diabetes Wall Street Journal Pfizer Inc. (PFE) has suspended studies of its drug tanezumab for treating chronic low back pain and nerve damage caused by diabetes at the request of the … Pfizer halts tanezumab studies on FDA request MarketWatch Pfizer halts third study of experimental pain drug The Associated Press Pfizer Suspends Chronic Pain Studies In Tanezumab Clinical Trial Program ..

Originally posted here:
Pfizer Halts Tanezumab Studies For Back Pain, Diabetes – Wall Street Journal

Leave a Reply

Name (required)

Mail (will not be published) (required)

Website

Comments

Wordpress theme developed by Simpler Computing and others - Wordpress and WPMU Plugins, custom code and more.